CD151 and hepatocellular carcinoma: Tumor growth potential, neoangiogenesis and metastasis following injection with a hepatocellular carcinoma cell line was also inhibited in mice that were treated with mAb 9B, which was shown to specifically disrupt the interaction between CD151 with integrin α6β1 (Ke et al., 2011).